MYT1L is a Candidate Gene for Intellectual Disability in Patients With 2p25.3 (2pter) Deletions

Servi J. C. Stevens*, Conny M. A. van Ravenswaaij-Arts, Jannie W. H. Janssen, Jolien S. Klein Wassink-Ruiter, Anthonie J. van Essen, Trijnie Dijkhuizen, Jeroen van Rheenen, Regina Heuts-Vijgen, Alexander P. A. Stegmann, Eric E. J. G. L. Smeets, John J. M. Engelen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

43 Citations (Web of Science)

Abstract

A partial deletion of chromosome band 2p25.3 (2pter) is a rarely described cytogenetic aberration in patients with intellectual disability (ID). Using microarrays we identified deletions of 2p25.3, sized 0.37-3.13 Mb, in three adult siblings and three unrelated patients. All patients had ID, obesity or overweight and/or a square-shaped stature without overt facial dysmorphic features. Combining our data with phenotypic and genotypic data of three patients from the literature we defined the minimal region of overlap which contained one gene, i.e., MYT1L. MYT1L is highly transcribed in the mouse embryonic brain where its expression is restricted to postmitotic differentiating neurons. In mouse-induced pluripotent stem cell (iPS) models, MYT1L is essential for inducing functional mature neurons. These resemble excitatory cortical neurons of the forebrain, suggesting a role for MYT1L in development of cognitive functions. Furthermore, MYT1L can directly convert human fibroblasts into functional neurons in conjunction with other transcription factors. MYT1L duplication was previously reported in schizophrenia, indicating that the gene is dosage-sensitive and that shared neurodevelopmental pathways may be affected in ID and schizophrenia. Finally, deletion of MYT1, another member of the Myelin Transcription Factor family involved in neurogenesis and highly similar to MYT1L, was recently described in ID as well. The identification of MYT1L as candidate gene for ID justifies further molecular studies aimed at detecting mutations and for mechanistic studies on its role in neuron development and on neuropathogenic effects of haploinsufficiency.
Original languageEnglish
Pages (from-to)2739-2745
JournalAmerican Journal of Medical Genetics Part A
Volume155A
Issue number11
DOIs
Publication statusPublished - Nov 2011

Keywords

  • MYT1L
  • intellectual disability
  • SNP array
  • array-CGH
  • deletion 2p25.3 (2pter)
  • neurogenesis

Cite this